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432 ® 1995 A nnual M eeting A b stra c ts MEDICAL DECISION MAKING
PHYSICIANS PREFERENCES BIAS TREATMENT CHOICE FOR DEEP VENOUS 
THROMBOSIS
R Soetikno nnd L Lenert. Department of Medicine, Stanford University, Stanford, CA.
Deep vein thrombosis (DVT) can. be treated with a thrombolytic drug (often streptokinase) followed 
by intravenous heparin or with intravenous heparin alone. The addition o f  streptokinase reduces the 
incidence or postthrombotic syndrome (PTS), but increases the risk o f  bleeding, stroke and death. In a 
recent article in NEJM 1995:330:1864-9, using decision analysis, O 'M eara et al. suggested that patient 
preferences favor use o f  heparin alone . However, preferences can vary with the sub jec t’s current health 
and knowledge of relevant health states. We hypothesized that, given a realistic description o f  the 
morbidity o f  PTS, many younger patients would have preferences consistent with use o f  streptokinase 
followed by intravenous heparin. However, the most com m on treatment for D V T  favors the use o f  
heparin alone, which reflects the physicians’ values for iatrogenic events rather than patient preferences.
We developed a multimedia utility assessm ent program  that describes mild and severe PTS, and 
stroke. We measured preferences for these outcomes in 30 young wom en and 30 randomly selected 
Internists from the Stanford Faculty, and then calculated the expected num ber o f  Q A LY s using O’Meara's 
decision model. In physicians, w e m easured the additional d isu til i ty  o f  an iatrogenic cause o f  
stroke/death using their utilities for PTS and responses to a clinical problem in which they traded a \ % 
risk of stroke/death from the use o f  streptokinase for varying gains from prevention o f  PTS.
Women and physician groups had similar preferences fot- PTS and stroke. 11% o f  subjects would 
accept an increased risk o f  death to avoid PTS (median utility 0.95), Treatment with the combination 
therapy yielded an average 0.13 QALYs over heparin alone (p *  0.21), Individualized therapy based on 
preferences increased expected QALYs by an additional 0.12 (pc .001). 24/30 physicians had valid 
responses to the clinical problem and 15/24 had utilities for PTS o f  < 1, allowing calculation o f  the 
additional disutility o f  an iatrogcnic cause for stroke/death. Utilities for stroke/death resulting from 
treatment with thrombolytics ranged from -0.2 to -33 (median -8,0),
Substantial numbers of patients may have preferences that favor treatment o f  D V T  with streptokinase 
followed by heparin rather than heparin alone. Physicians often place an additional negative weight on 
iatrogenic causcs o f  health states that may bias them against the use o f  streptokinase. Choice o f  therapy 
for DVT should be guided by formal or informal assessment o f  patient preferences.
THE INFLUENCE OF A PHYSICIAN'S OWN ETHNICITY AND GENDER ON ORIENTATION TO 
SUBSTANCE ABUSE PATIENTS
JM Merrill. R Lorimor. R Romem. J Schindler. J Thornbv. M Holleman. and C Vallbona. Department 
of Community Medicine, Baylor College of Medicine, Houston, Texas
OBJECTIVE: To explore the effect of a physician's own ethnicity, gender and type of medical 
practice on their decision making toward management of substance abuse patients. METHODS: 
A cross-sectional survey, administered to physicians working In Inner-city community health clinics, 
measured attribution al style (AS) toward substance abuse patients, personal characteristics, and 
professional role traits by physicians' gender, ethnicity, and type of medical practice. Results: 
African-American physicians had the most positive orientation toward substance abuse patients and 
Hispanic physicians had the most negative (p<0,05) with white and Asian-Americans between. 
LISREL showed that negative AS toward substance abuse patients was predicted by physician 
authoritarianism (psO.OOOl) and intolerance to clinical ambiguity (psO.OS), Among the four ethnic 
groups surveyed, African-American physicians were the least authoritarian and the most tolerant 
of clinical uncertainty (psO.OS). Aslan-Americans scored highest on reliance on high-technology 
medicine, differing significantly from both African-Americans and whites (psO.OS) but not Hispanics. 
Pediatricians scored highest on negative AS toward substance abuse patients , authoritarianism, 
reliance on high-technology medicine, and intolerance to uncertainty In clinical medicine {ps0.05). 
Because all pediatricians surveyed were women, ANOVA restricted to females was performed by 
type of medical practice. Female pediatricians scored significantly higher on negative AS toward 
substance abuse patients than did other female physicians (p<0.05). They were also more 
authoritarian <p<0.05) and more intolerant of clinical uncertainty (p<.05), Among these inner-city 
physicians, African-Americans had the most positive decision making characteristics toward 
substance abuse patient management.
QUALITY OF LIFE A N D  T H E  T R E A T M E N T  CH OICE O F SU C C ESSFU LLY  TR EA T ED  
LA R Y N G E A L CA N CER PATIENTS.
J. Donk van der. P .F .M . Krabbe. J .D .F .  Hahbem a. P.C. Levendau. C .A , Meeuwis. P .I .M . 
Schmitz. D r. Daniel den Hoed Cancer Center, Rotterdam , Center for Decision Sciences, Department 
o f  Public Health, Erasmus University Rotterdam and the Department o f  Medical Psychology and 
Psychotherapy, Erasmus University Rotterdam.
‘Purpose, Quality o f  life (QoL) and treatment choice was assessed in 24 successfully treated laryngeal 
cancer patients. The results on QoL and treatment choice were compared with a control group o f  24 
respondents from the general population who also cooperated this study. All patients were more than 
3 years free o f  disease and had a history o f  radiation therapy (RT, n =  9) or surgery  plus additional 
radiation therapy (S -f ,  n =  15) and volunteered in a clinical decision making study,
M ethods. F o r  measuring Q oL  we have used generic (NHP, E uroQ ol, K am afsky) and specific 
(RSCL, H A D ) questionnaires that were completed before the respondents entered the study. 
Treatment choice was elicited by means o f  a direct comparison using self-dev eloped health scenarios 
for two treatment modalities (RT vs S + ) .  Additionally, w e studied the differences on these measures 
between the patients who were treated by RT and patients w ho w ere treated by S +  as primary 
treatment.
Results. In general no significant differences were found between the patients and the control group, 
except for the NHP. Patients indicated less pain, less sleeping problems and w ere socially leas 
isolated than the control group, Comparison o f  the results between the patient groups (RT and S + )  
showed thnt the RT patients experience significantly less physical and psychological distress. 
Furthermore, they had a better se[f-admini.strated functional status than the S-f group. We were not 
able to delect if these results were caused by patient selection or treatment effects.
W ith respect to the treatment choice, 19 (80% ) respondents from the control group preferred 
radiation therapy. In the patient group all patients who were treated by R T  preferred radiation 
therapy (100% ) while in the S +  group, 8 out o f  15 (53% ) patients preferred radiation therapy. 
C onclusions. In general successfully treated laryngeal cancer patients showed no decreased in QoL, 
although w e observed differences between the RT and S-f group. No relation was found between 
Q oL and treatment choice.
DISEASE-SPECIFIC HEALTH STATES: DETERMINING CRITERIA FOR OPTIMAL 
INSTRUMENT CONSTRUCTION IN COST-UTILITY ANALYSES
K Gold1. J Weeks2 . E-Lee1. G Gusman1. K -Schulman1, 1 Department of Medicine,
Georgetown University, Washington, DC, ^Dana-Farber Cancer Institute,
Boston, MA.
The use o f health states has become an essential cornerstone for many 
cost-utiliLy and quality o f life year analyses, Since many existing instruments 
used to generate health states have not been tailored for this use, the resultant 
data does not facilitate maximally informative analyses in these arenas of 
research. This paper provides a meLliodology for the development of disease- 
specific health states for use in health utility assessments. This methodology 
includes the following: 1) a qualitative discussion o f objective and subjective 
criteria for classification; 2) recommended psychometric properties involving 
state discrimination and power which affect the efficacy of ensuing analyses; 
3) strategic considerations in instrument construction which allow for 
flexible selection o f  states based on a post-hoc evaluation of classification 
functionality in a study. In addition to this methodology, we present a worked 
example o f an instrument developed for evaluating health states of elderly 
women with early stage breast cancer, Using SF-36 data from a study of 260 
hospitalized elderly, we present a cluster analysis which assisted in selecting 
key attributes that highly discriminate between elderly individuals. The 
analysis indicated that the data is characterized by seven clusters. Within 
each cluster, one or two questionnaire items showed superior discriminating 
power in this population. This information was incorporated into a strategic 
design of a set o f health states that addressed other substantive and practical 
issues. This methodology may serve as a useful link in the development of 
population-specific preference measures for use in clinical trials.
ASSESSM ENT OF INDIVIDUAL TR EA TM EN T PREFERENCES FOR T3-LARYNGEAL 
CA N CER:EFFECTS OF TIM E AND DISEASE AND TREA TM EN T RELATED KNOW LEDGE
J. Donk van der. P .F .M .  Krahbe. J .D .F .  Habhema. P .C . Levenda«. C .A . Meemvis. P .I .M . 
Schmitz. Dr. Daniel den Hoed Cancer Center, Rotterdam  and Center for Decision Sciences, 
Department o f  Public Health, Erasmus University Rotterdam and the Department o f  Medical 
Psychology und Psychotherapy, Erasmus University Rotterdam.
P u rp o se .  To  study the consistency o f  individual treatment preferences for T3-laryngenl cancer in a 
group o f  successfully treated laryngenl cancer patients and in a control group o f  respondents from 
the general population with a repeated measurement design (TI -T4).
M ethods .  T h is  study consisted of three interview sessions that w ere performed with an interval of 
two weeks. Utilities for two treatment modalities, i.e. radiation therapy (RT) and surgery plus 
additional radiation therapy (S -f)  were elicited by means o f  the time trade-off (TTO). In the first 
interview the respondents were instructed to use the time trade-off method, whereafter the utilities 
w ere  elicited for the first tim e (T l) .  In the second interview, between the second and the third 
elicitation o f  utilities, extensive information about the disease and treatment related aspects was 
provided. This educational part o f  the study had a duration o f  about 60 min. and consisted o f  an oral 
presentation, a booklet and a video presentation. Before and after the education, utilities were 
elicited (T2 - T3). In the third interview, two weeks later, utilities w ere elicited for the fourth time 
(T4). Correlational analysis were performed and individual treatment choices were computed for 
each measurement moment (T l - T4) nnd expressed in quality adjusted life expectancies (QALE). 
R esu lts .  The patient group showed higher QA LE for both treatment modalities compared to the 
control group. Over time, substantial variation was observed between ihe four measurement 
moments. On an individual level, changes in the calculated treatment choices were observed in both 
the pntient group and the control group between the four measurement moments.
C onclusions. The results show  that individual treatment preferences change over time and are 
influenced by treatment and disease related knowledge. The mechanisms for these changes, 
especially the effects o f  education, are not yet clear.
INFORMATION FRAMING IN  PHYSICIAN DESCRIPTION OF TREATMENT 
OPTIONS FOR CANCER PATIENTS
KR Yabroff1. LE Rubenstein1. KF Gold1. C Lerman1. C Weaver2 . NJ Meropol3 . KA 
SnM man , Georgetown University Medical Center, Washington, DC, Response 
Technologies, Memphis, Tennessee, ^Roswell Park Cancer Institute, Buffalo, New York.
Patients with metastatic breast cancer frequently undergo aggressive therapy that 
has an uncertain quality-adjusted survival advantage. Framing theory suggests that 
individuals may not maximize their expected utility if  presented with treatment 
options described in the negative (focused on the tumor), as opposed to the same 
information described in the positive (focused on remaining quality of life). We 
developed a survey to assess treatment recommendations by oncologists who offer 
stem-cell transplant therapy to their patients. The survey collected demographic data 
and written descriptions of the treatment recommendations for three standardized 
patient scenarios. Analysis of the closed-ended questions included descriptive 
statistics and log-linear regression o f  the recommendation o f aggressive treatment 
across the three scenarios on physician characteristics and practice patterns. The 
survey was sent to 155 oncologists affiliated with a private stem-cell transplant 
network, with 60% responding. 22% of physicians recommended aggressive 
treatment for all three scenarios, 33% in only two scenarios and 45% in only one 
scenario. In univariate analysis, physicians who recommended stem cell 
transplantation in all three cases were likely to do so to improve survival (p<0.001) 
and were more likely to present the information in a negative frame. Physicians who 
did not recommend stem cell transplantation in all cases were more likely to 
recommend an alternative treatment to improve quality o f life (p<0.02). This study 
provides evidence that physicians may frame the description o f  treatment options 
when informing patients about aggressive cancer therapies.
